Back to Search
Start Over
Management and outcomes of patients with unstable angina with undetectable, normal, or intermediate hsTnT levels.
- Source :
-
Clinical research in cardiology : official journal of the German Cardiac Society [Clin Res Cardiol] 2020 Apr; Vol. 109 (4), pp. 476-487. Date of Electronic Publication: 2019 Jul 19. - Publication Year :
- 2020
-
Abstract
- Background: Patients with unstable angina (UA) are regarded to be at low risk for future coronary events. Guidelines discourage routine coronary angiography and recommend early discharge after individualized risk stratification. The relative value of clinical risk indicators as compared to cardiac troponin (cTn) alone is unsettled in the era of high-sensitivity cardiac troponin (hsTn) assays. We aimed to investigate the clinical characteristics, therapies, and outcomes of UA patients with different hsTnT concentrations.<br />Methods: During 12 months, 2525 patients were enrolled. UA was defined as unstable symptoms and either undetectable (< 5 ng/L), normal (5-14 ng/L) or stable elevated hsTnT (15-51 ng/L). Follow-up for 1-year mortality was available in 98.7%.<br />Results: A total of 280 patients (11.1%) received a diagnosis of UA. Mortality rates at 12 months were 0%, 1.9% and 6.9% in presence of undetectable, normal and stable elevated hsTnT. Elevated hsTnT > 99th percentile but not unstable symptoms carried an independent 3.25-fold (1.78-5.93) higher risk for all-cause death after adjustment for other clinical risk indicators or the GRACE score. Utilization of guideline-recommended therapies was high albeit lower than for non-ST-elevation myocardial infarction (NSTEMI). Significantly fewer patients with UA received dual antiplatelet therapy (DAPT, odds ratio (OR) 0.51 [95% CI 0.44-0.59], P < 0.0001), coronary angiography (CA, OR 0.79, [95% CI 0.74-0.87], P < 0.0001), and percutaneous coronary intervention (PCI, OR 0.50, [95% CI 0.40-0.61], P < 0.0001), compared to NSTEMI. However, prevalence of significant obstructive coronary artery disease requiring PCI was 31.8%, even in patients with undetectable hsTnT, indicating the need for stress testing.<br />Conclusions: The current dichotomization of patients into UA and NSTEMI is no longer appropriate. Additional risk stratification seems warranted including the presence and magnitude of hsTn concentration and additional risk indicators. Clinical Trials Identifier: NCT03111862.
- Subjects :
- Adult
Aged
Aged, 80 and over
Angina, Unstable diagnosis
Angina, Unstable mortality
Angina, Unstable therapy
Biomarkers blood
Female
Humans
Male
Middle Aged
Non-ST Elevated Myocardial Infarction diagnosis
Non-ST Elevated Myocardial Infarction mortality
Non-ST Elevated Myocardial Infarction therapy
Predictive Value of Tests
Prevalence
Prognosis
Registries
Risk Assessment
Risk Factors
Time Factors
Angina, Unstable blood
Non-ST Elevated Myocardial Infarction blood
Troponin T blood
Subjects
Details
- Language :
- English
- ISSN :
- 1861-0692
- Volume :
- 109
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Clinical research in cardiology : official journal of the German Cardiac Society
- Publication Type :
- Academic Journal
- Accession number :
- 31325044
- Full Text :
- https://doi.org/10.1007/s00392-019-01529-4